Skip to content ↓

MISTI seeks proposals for Global Seed Funds; deadline is Sept. 15

Funds support MIT faculty, researchers in launching international projects and collaboration.
Associate Professor of Mechanical Engineering Thomas Peacock worked with colleagues at the Coriolis platform, the world's largest rotating table, in Grenoble, France, as a part of his MIT-France Seed Fund grant.
Caption:
Associate Professor of Mechanical Engineering Thomas Peacock worked with colleagues at the Coriolis platform, the world's largest rotating table, in Grenoble, France, as a part of his MIT-France Seed Fund grant.

MIT International Science and Technology Initiatives (MISTI) is calling for proposals for its latest round of Global Seed Funds — grants that support MIT faculty and researchers in launching international projects and collaboration.

Applicants are encouraged to involve MIT students — both undergraduate and graduate — in their projects.

The seed-fund program includes a general fund for projects anywhere in the world and nine country funds. This year’s grant round includes two new funds for projects in Brazil and China. The award may be used to cover travel, meeting and workshop costs to facilitate international projects and collaboration. In 2009, MISTI awarded $664,793 to 43 projects across the Institute.

The deadline for the current round is Wednesday, Sept. 15. For more details and to download the short application form visit http://web.mit.edu/misti/faculty/.

Related Links

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story